All Essays

Week in Review

Week in Review

Lawsuits filed over FDA cigarette label rule, EPA decision on carbon monoxide, SEC whistleblower program, and more.

11th Circuit Finds Affordable Care Act’s Individual Mandate Unconstitutional

11th Circuit Finds Affordable Care Act’s Individual Mandate Unconstitutional

Decision splits circuits, sparking responses from presidential candidates.

11th Circuit Rejects Unlimited Power to Impose Federal Mandates

11th Circuit Rejects Unlimited Power to Impose Federal Mandates

The appeals court demonstrates why health insurance requirement is unconstitutional.

Senator Franken Supports Bloomberg’s Battle Against Comcast

Senator Franken Supports Bloomberg’s Battle Against Comcast

The FCC considers whether the cable provider is favoring its own news channels.

FDA Issues Reports on International Collaboration

FDA Issues Reports on International Collaboration

Agency reports on pilot programs to increase international regulatory collaboration.

FINRA Executive Compensation Challenged by Member Firms

FINRA Executive Compensation Challenged by Member Firms

Recent report details last year’s compensation.

Week in Review

Week in Review

HIV treatment approval, e-rulemaking report, heavy truck fuel efficiency rules and more.

New Cost-Benefit Website for Criminal Justice

New Cost-Benefit Website for Criminal Justice

Website can be resource for criminal law policymakers.

Congress Needs Its Own Regulatory Review Office

Congress Needs Its Own Regulatory Review Office

OIRA oversight of regulation is necessary, but not sufficient.

Expand Centralized Regulatory Review to Independent Agencies

Expand Centralized Regulatory Review to Independent Agencies

Congress should require independent regulatory commissions to perform cost-benefit analyses

New Recommendations for Valuing Mortality Risk Reductions

New Recommendations for Valuing Mortality Risk Reductions

EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.

Week in Review

Week in Review

‘Gluten free’ to be clarified, Chemical Data Reporting rule, cable provider regulations, and more.